Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
1.060
+0.050 (4.95%)
At close: May 5, 2025, 4:00 PM
1.050
-0.010 (-0.94%)
Pre-market: May 6, 2025, 5:47 AM EDT

Tevogen Bio Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
23.434.448.431.66
Research & Development
30.144.45.292.96
Operating Expenses
53.568.8413.724.62
Operating Income
-53.56-8.84-13.72-4.62
Interest Expense
-0.18-1.21-0.93-0.6
Interest & Investment Income
-000
Other Non Operating Income (Expenses)
-0.95---
EBT Excluding Unusual Items
-54.7-10.05-14.66-5.22
Merger & Restructuring Charges
-7.5---
Other Unusual Items
48.47-50.43-7.38-10.38
Pretax Income
-13.73-60.48-22.04-15.6
Net Income
-13.73-60.48-22.04-15.6
Preferred Dividends & Other Adjustments
-3.45---
Net Income to Common
-10.27-60.48-22.04-15.6
Shares Outstanding (Basic)
147252525
Shares Outstanding (Diluted)
147252525
Shares Change (YoY)
492.57%-1.98%0.69%-
EPS (Basic)
-0.07-2.44-0.87-0.62
EPS (Diluted)
-0.07-2.44-0.87-0.62
Free Cash Flow
-12-8.3-9.13-5.38
Free Cash Flow Per Share
-0.08-0.34-0.36-0.21
EBITDA
-53.4-8.68-13.63-4.61
D&A For EBITDA
0.160.160.090.01
EBIT
-53.56-8.84-13.72-4.62
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q